Johnson Chemical Pharmaceutical Works Co Ltd (TWO:4747) — Market Cap & Net Worth
Market Cap & Net Worth: Johnson Chemical Pharmaceutical Works Co Ltd (4747)
Johnson Chemical Pharmaceutical Works Co Ltd (TWO:4747) has a market capitalization of $68.18 Million (NT$2.16 Billion) as of September 17, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #20805 globally and #1236 in its home market, demonstrating a -5.74% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Johnson Chemical Pharmaceutical Works Co Ltd's stock price NT$23.80 by its total outstanding shares 90922064 (90.92 Million). Also see 4747 total asset value for a full breakdown of the balance sheet.
Johnson Chemical Pharmaceutical Works Co Ltd Market Cap History: 2015 to 2026
Johnson Chemical Pharmaceutical Works Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $76.00 Million to $68.18 Million (-0.59% CAGR). Also see Johnson Chemical Pharmaceutical Works Co operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Johnson Chemical Pharmaceutical Works Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Johnson Chemical Pharmaceutical Works Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Johnson Chemical Pharmaceutical Works Co (4747) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.30x
Johnson Chemical Pharmaceutical Works Co Ltd's market cap is 0.30 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.17x
Johnson Chemical Pharmaceutical Works Co Ltd's market cap is 3.17 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $67.99 Million | $392.42 Million | $63.45 Million | 0.17x | 1.07x |
| 2017 | $76.68 Million | $394.61 Million | $60.01 Million | 0.19x | 1.28x |
| 2018 | $80.38 Million | $411.91 Million | $57.28 Million | 0.20x | 1.40x |
| 2019 | $84.28 Million | $425.34 Million | $64.47 Million | 0.20x | 1.31x |
| 2020 | $83.82 Million | $424.01 Million | $63.56 Million | 0.20x | 1.32x |
| 2021 | $83.07 Million | $411.49 Million | $49.10 Million | 0.20x | 1.69x |
| 2022 | $126.92 Million | $494.67 Million | $64.85 Million | 0.26x | 1.96x |
| 2023 | $234.89 Million | $606.71 Million | $79.70 Million | 0.39x | 2.95x |
| 2024 | $204.81 Million | $611.41 Million | $84.12 Million | 0.33x | 2.43x |
| 2025 | $169.58 Million | $569.77 Million | $53.51 Million | 0.30x | 3.17x |
Competitor Companies of 4747 by Market Capitalization
Companies near Johnson Chemical Pharmaceutical Works Co Ltd in the global market cap rankings as of September 17, 2026. Review Johnson Chemical Pharmaceutical Works Co tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Johnson Chemical Pharmaceutical Works Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #519 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #633 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #640 globally with a market cap of $43.16 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.62 Billion USD ( CN¥277.61 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #519 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #633 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #640 | GALDERMA GROUP AG | NYSE:GALDY | $43.16 Billion | $37.02 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.62 Billion | CN¥43.52 |
Johnson Chemical Pharmaceutical Works Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Johnson Chemical Pharmaceutical Works Co Ltd's market cap moved from $76.00 Million to $ 68.18 Million, with a yearly change of -0.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$68.18 Million | -59.80% |
| 2025 | NT$169.58 Million | -17.20% |
| 2024 | NT$204.81 Million | -12.80% |
| 2023 | NT$234.89 Million | +85.07% |
| 2022 | NT$126.92 Million | +52.79% |
| 2021 | NT$83.07 Million | -0.90% |
| 2020 | NT$83.82 Million | -0.54% |
| 2019 | NT$84.28 Million | +4.85% |
| 2018 | NT$80.38 Million | +4.83% |
| 2017 | NT$76.68 Million | +12.78% |
| 2016 | NT$67.99 Million | -10.55% |
| 2015 | NT$76.00 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Johnson Chemical Pharmaceutical Works Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $68.18 Million USD |
| MoneyControl | $68.18 Million USD |
| MarketWatch | $68.18 Million USD |
| marketcap.company | $68.18 Million USD |
| Reuters | $68.18 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Johnson Chemical Pharmaceutical Works Co Ltd
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, card… Read more